The Role of DNA Repair Pathways in Antibody Somatic Hypermutation

In a recent online publication in SCIENCE CHINA Life Sciences, researchers from the laboratory of Leng-Siew Yeap at the Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine published a review article entitled "Molecular Mechanisms of DNA Lesion and Repair During Antibody Somatic Hypermutation". This review comprehensively summarizes the mechanisms involved in the generation of antigen-specific diversified antibodies, with a particular focus on the mechanisms that generate high-frequency point mutations and low-frequency deletions and insertions (indels) in antibody genes.

Antibodies, as specialized immunoglobulin (Ig) proteins produced and secreted by B cells in the immune system, play an essential role in recognizing and binding antigens to combat pathogen invasion. However, the diversity and efficacy of antibodies are not inherent properties but are achieved through finely regulated molecular mechanisms. Somatic hypermutation of antibody genes represents a critical step in antibody diversification. This process involves a series of mutational events, including point mutations and indels, which alter the amino acid sequence of antibodies and affect their affinity for antigens. The mechanisms underlying these mutational events have been a focus of basic immunological research.

During SHM, activation-induced cytidine deaminase (AID) can bind to single-stranded DNA and convert cytosine (C) to uracil (U), resulting in U:G mismatches. These mismatches can be recognized by factors involved in the base excision repair (BER) or mismatch repair (MMR) pathways, resulting in point mutation and indels. This review systematically elucidates the molecular mechanisms underlying the generation of these mutational events. Mutations at C/G sites are primarily generated by DNA replication or BER pathways, whereas mutations at A/T sites are primarily generated by the MMR pathway. Indels are primarily generated through the BER pathway, with 1-bp insertions potentially occurring through the MMR pathway.

Translesion synthesis (TLS) polymerases play a critical role during SHM. This review comprehensively summarizes the different functions of nine TLS polymerases during SHM, such as Polη, which is mainly responsible for generating mutations at A/T sites and 1-bp insertions, REV1, which is mainly involved in C/G site replacement mutations, and Polλ, which is mainly involved in generating long insertions.

In conclusion, this review provides a comprehensive overview of the molecular mechanisms underlying various mutational outcomes and extensively summarizes the functional characteristics of TLS polymerases during SHM, providing theoretical foundations for vaccine design and the generation of broadly neutralizing antibodies that often harbor extraordinarily high mutations including the rare indel events.

Dr. Qian Hao, a research associate in the Yeap lab, is the first author of this review. This review was supported by funding from the National Key R&D Program of China, the National Natural Science Foundation of China, and the Shanghai Jiao Tong University 2030 Initiative.

Source:
Journal reference:

Hao, Q., et al. (2024). Molecular mechanisms of DNA lesion and repair during antibody somatic hypermutation. Science China Life Sciences. doi.org/10.1007/s11427-024-2615-1.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
29 Novel Antibodies Targeting Drug-Resistant Klebsiella Pneumoniae Identified